If UTI symptoms emerge after starting semaglutide or tirzepatide, contact your healthcare provider promptly for urinalysis and possible urine culture
While these events were generally mild and rarely led to treatment discontinuation, this represents a unique side effect profile that prospective users should understand before starting treatment
Joe Nadglowski President & CEO, Obesity Action Coalition #ObesityCare #Medicare #GLP1 #HealthPolicy #OAC #OCAN To view or add a comment, sign in Folks with Medicare who are taking a GLP-1 drug should be aware of this new and important cost-saving program, which begins July 1, 2026
Our team helps manage symptoms with personalized strategies and dose modifications when needed
Plant Mol Biol 21:923927 Hopkins FG, Morgan EJ (1938) Some relations between ascorbic acid and glutathione
Some medical providers may recommend NAD+ as part of a wellness or metabolic support plan